www.fdanews.com/articles/123528-boston-scientific-stent-inferior-to-abbott-labs-8217-study-says
Boston Scientific Stent Inferior to Abbott Labs’, Study Says
January 8, 2010
Boston Scientific Corp.’s Taxus Liberte stent shouldn’t be used in routine clinical practice because it’s inferior in terms of safety
and efficacy to Abbott Laboratories’ Xience V product, said researchers writing in The Lancet medical journal.
Daily Herald
Daily Herald